Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials
ConclusionIntravenous beta-blockers improved the MSI, decreased the risk of VT/VF in the first 24 h, and were associated with increased LVEF at 1 week and 6 months following PCI. In particular, intravenous beta-blockers started before PCI is beneficial for patients with LAD lesions.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Angioplasty | Arrhythmia | Atrial Fibrillation | Beta-Blockers | Cardiogenic Shock | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Databases & Libraries | Electrocardiogram | Heart | Heart Attack | Heart Failure | MRI Scan | Percutaneous Coronary Intervention | Stroke | Study | Ventricular Tachycardia